Extending Outcomes: Epidermal Growth Factor Receptor–Targeted Monoclonal Antibodies in Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Extending Outcomes: Epidermal Growth Factor Receptor–Targeted Monoclonal Antibodies in Non–Small-Cell Lung Cancer

Published:2009-03 Issue: Volume:10 Page:S24-S29
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Joy Anil A.,Butts Charles A.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference66 articles.

1. Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials;J Clin Oncol,2008

2. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer;Sandler;N Engl J Med,2006

3. FDA drug approval summary: bevacizumab (Avastin) plus carboplatin and paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer;Cohen;Oncologist,2007

4. Randomised, double-blind multicentre phase III study of bevacizumab in combination with cisplatin and gemcitabine in chemotherapy-naive patients with advanced or recurrent non-sqamous nonsmall cell lung cancer (NSCLC): BO17704;Manegold;J Clin Oncol,2007

5. Cetuximab for the treatment of colorectal cancer;Jonker;N Engl J Med,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperactivation of constitutively dimerized oncogenic EGF receptors by autocrine loops;Oncogene;2012-07-02

2. Targeting EGFR in non-small-cell lung cancer: Lessons, experiences, strategies;Respiratory Medicine;2012-02

3. The Role of Irreversible HER Family Inhibition in the Treatment of Patients with Non-Small Cell Lung Cancer;The Oncologist;2011-10-20

4. Lung Adenocarcinoma: Lessons in Translation from Bench to Bedside;Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine;2010-11

5. Epithelial to mesenchymal transition: The doorway to metastasis in human lung cancers;The Journal of Thoracic and Cardiovascular Surgery;2010-09